SCM
AGN

Suvretta Capital Management’s Allergan plc AGN Stock Holding History

Suvretta Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,000
Closed -$536K – 36
2016
Q1 		$536K Buy
+2,000
New +$573K 0.02% 23
2015
Q4 		– Sell
-90,000
Closed -$24.5M – 29
2015
Q3 		$24.5M Buy
+90,000
New +$27.6M 2.59% 10

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Suvretta Capital Management's AGN Position: Q4 2016 in Review

Suvretta Capital Management sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 466,300 shares — an estimated $107M sold.

Suvretta Capital Management first reported a position in AGN in Q4 2013 and held it in 11 quarters. The position peaked at $230M in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Suvretta Capital Management reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Suvretta Capital Management sold 466,300 Allergan plc shares in Q4 2016, an estimated $107M.
  • Suvretta Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 11 quarters.
  • Suvretta Capital Management's Allergan plc position peaked at $230M in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Suvretta Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.